CATX – perspective therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Perspective Therapeutics Announces Acceptance of VMT-a-NET Data for Presentation at the AACR Annual Meeting 2026
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results
Perspective Therapeutics (NASDAQ:CATX) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Perspective Therapeutics (NASDAQ:CATX) was given a new $16.00 price target on by analysts at Piper Sandler. They now have an "overweight" rating on the stock.
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
Form 10-K Perspective Therapeutics For: Dec 31
Form 8-K Perspective Therapeutics For: Mar 16
Form SCHEDULE 13G Perspective Therapeutics Filed by: Avidity Partners Management LP
Form 4 Perspective Therapeutics For: Mar 02 Filed by: Martinez Maria E
Form 4 Perspective Therapeutics For: Mar 02 Filed by: Morich Frank
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.